Inducible nitric oxide synthase and cardiovascular disease

Cardiovascular Research

Volumn 45, Issue 1, 2000, Pages 148-155

  Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adenosine; Arrhythmia (mechanisms); Contractile function; Ischemia; Preconditioning; Reperfusion

Indexed keywords

ISOENZYME; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; ENZYME INDUCTION; GRAFT REJECTION; HEART FAILURE; HUMAN; IN VITRO STUDY; MORTALITY; MYOCARDITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SHOCK, SEPTIC;

EID: 0033991128     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00316-8     Document Type: Review

References (111)

1. Bredt D.S., Hwang P.M., Glatt C.E., et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
2. Lamas S., Marsden P.A., Li G.K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 89:1992;6348-6352.
3. Sessa W.C., Harrison J.K., Barber C.M., et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 267:1992;15274-15276.
4. Xie Q.-W., Cho H.J., Calaycay J., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
5. Forstermann U., Boissel J.P., Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS1 and NOSIII). FASEB J. 12:1998;773-790.
6. Mayer B., Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 22:1997;477-481.
7. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
8. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
9. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
10. Stuehr D., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to E. coli lipolysaccharide. Proc Natl Acad Sci USA. 82:1985;7738-7742.
11. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
12. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 2:1989;997-1000.
13. Vallance P., Collier J., Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium-dependent dilatation in human veins in vivo. Cardiovasc Res. 23:1989;1053-1057.
14. Wright C.E., Rees D.D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 26:1992;48-67.
15. Fleming I., Gray G.A., Julou-Schaeffer G., Parratt J.R., Stoclet J.-C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun. 171:1990;562-568.
16. G-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity. Life Sci. 48:1991;189-193.
17. Thiemerman C., Vane J.R. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat in vivo. Eur J Pharmacol. 182:1990;591-595.
18. G-monomethyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA. 87:1990;3629-3632.
19. Rees D.D., Cellek S., Palmer R.M.J., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 173:1990;541-547.
20. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
21. Brady A.J.B., Poole-Wilson P.A., Harding S.E., Warren J.B. Nitric oxide within cardiac myocytes reduces their contractility in endotoxaemia. Am J Physiol. 263:1992;H1963-H1966.
22. Balligand J.L., Ungureanu D., Kelly R., et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
23. de Belder A.J., Radomski M.W., Why H.J., et al. Nitric oxide synthase in human myocardium. Lancet. 341:1993;84-85.
24. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 1999. In press.
25. Lewis M.J., Shah A.M. Endothelial modulation of cardiac function. 1997;Harwood Academic Publishers, Amsterdam.
26. Shen W., Hintze T.H., Wolin M.S. Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation. 92:1995;1086-1095.
27. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
28. Xu K.Y., Huso D.L., Dawson T., Bredt D.S., Becker L.C. NO synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA. 96:1999;657-662.
29. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 271:1996;C1424-C1437.
30. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 100:1997;2153-2157.
31. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 269:1994;27580-27588.
32. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1β and IFN-γ Am J Physiol. 268:1995;H1293-H1303.
33. Tsujino M., Hirata Y., Imai T., et al. Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation. 90:1994;375-383.
34. i and cell contraction in cultured chick ventricular myocytes. Circ Res. 75:1994;285-295.
35. Stein B., Frank P., Schmitz W., Scholz H., Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol. 28:1996;1631-1639.
36. Fukuchi M., Hussain S.N.A., Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy. Circulation. 98:1998;132-139.
37. Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 1999. In press.
38. Simmons W.W., Closs E.I., Cunningham J.M., Smith T.W., Kelly R.A. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem. 271:1996;11694-11702.
39. Evans H.G., Lewis M.J., Shah A.M. Interleukin-1β modulates myocardial contraction via dexamethasone-sensitive production of nitric oxide. Cardiovasc Res. 27:1993;1486-1490.
40. Tao S., McKenna T.M. In vitro endotoxin exposure induces contractile dysfunction in adult rat cardiac myocytes. Am J Physiol. 267:1994;H1745-H1752.
41. Schulz R., Panas D.L., Catena R., et al. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α Br J Pharmacol. 114:1995;27-34.
42. 2+ in cardiac myocytes. Circ Res. 81:1997;1011-1020.
43. Ungureanu-Longrois D., Balligand J.L., Okada I., et al. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res. 77:1995;486-493.
44. Pinsky D.J., Cai B., Yang X., et al. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest. 95:1995;677-685.
45. Ing D.J., Zang J., Dzau V.J., Webster K.A., Bishopric N.H. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res. 84:1999;21-33.
46. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
47. i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol. 271:1996;H1449-H1455.
48. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA. 93:1996;6770-6774.
49. Gardiner S.M., Kemp P.A., March J.E., Bennett T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol. 116:1995;2005-2016.
50. Karupiah G., Xie Q., Buller R.M.L., et al. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261:1993;1445-1448.
51. Pacelli R., Wink D.A., Cook J.A., et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med. 182:1995;1469-1479.
52. Xie Y.-W., Kaminski P.M., Wolin M.S. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res. 82:1998;891-897.
53. Schulz R., Dodge K.L., Lopaschuk G.D., Clanachan A.S. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol. 272:1997;H1212-H1219.
54. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
55. Parrillo J. Pathogenetic mechanisms of septic shock. New Engl J Med. 328:1993;1471-1477.
56. Bone R.C., Grodzin C.J., Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 112:1997;235-243.
57. Meyer J., Lentz C.W., Stothert J.C., et al. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med. 22:1994;306-312.
58. Rees D.D., Monkhouse J.E., Cambridge D., Moncada S. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol. 124:1998;540-546.
59. Petros A., Lamb G., Leone A., et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 28:1994;34-39.
60. Wray G.M., Millar C.G., Hinds C.J., Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock. 9:1998;329-335.
61. MacMicking J.D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
62. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA. 92:1995;10688-10692.
63. Wei X.Q., Charles I.G., Smith A., et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
64. Laubach V.E., Foley P.L., Shockey K.S., Tribble C.G., Kron I.L. Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice. Am J Physiol. 275:1998;H2211-H2218.
65. Gunnett C.A., Chu Y., Heistad D.D., Loihl A., Faraci F.M. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol. 275:1998;H416-H421.
66. Hickey M.J., Sharkey A., Sihota E.G., et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:1997;955-964.
67. Bhagat K., Collier J., Vallance P. Local venous responses to endotoxin in humans. Circulation. 94:1996;490-497.
68. Cantoni L., Rossi C., Rizzardini M., Gadina M., Ghezzi P. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Biochem J. 279:1991;891-894.
69. Yet S.-F., Pellacani A., Patterson C., et al. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem. 272:1997;4295-4301.
70. Pellacani A., Wiesel P., Sharma A., et al. Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-β1. Circ Res. 83:1998;396-403.
71. Zakhary R., Gaine S.P., Dinerman J.L., et al. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA. 93:1996;795-798.
72. Sammut I.A., Foresti R., Clark J.E., et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol. 125:1998;1437-1444.
73. Wu C.C., Chen S.J., Yen M.H. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats. Am J Physiol. 275:1998;H1148-H1157.
74. Durante W., Kroll M.H., Christodoulides N., Peyton K.J., Schafer A.I. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res. 80:1997;557-564.
75. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med. 4:1998;1392-1396.
76. Luss H., Watkins S.C., Freeswick P.D., et al. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol. 27:1995;2015-2029.
77. Liu S.F., Barnes P.J., Evans T.W. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med. 25:1997;512-518.
78. Thoenes M., Forstermann U., Tracey W.R., et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol. 28:1996;165-169.
79. Kooy N.W., Lewis S.J., Royall J.A., et al. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med. 25:1997;812-819.
80. Decking U.K.M., Flesche C.W., Gödecke A., Schrader J. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol. 268:1995;H2460-H2465.
81. Keller R.S., Jones J.J., Kim K.F., et al. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock. 4:1995;338-344.
82. Klabunde R.E., Coston A.F. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock. 3:1995;73-78.
83. Meng X., Ao L., Brown J.M., et al. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock. 7:1997;111-118.
84. McDonough K.H., Smith T., Patel K., Quinn M. Myocardial dysfunction in the septic rat heart: role of nitric oxide. Shock. 10:1998;371-376.
85. 2+ in septic shock: lack of role for nitric oxide. J Mol Cell Cardiol. 30:(abstract supplement):1998;A44.
86. Quezado Z.M.N., Karzai W., Danner R.L., et al. Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs. Am J Respir Crit Care Med. 157:1998;1397-1405.
87. Liu S.F., Adcock I.M., Old R.W., Barnes P.J., Evans T.W. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med. 24:1996;1219-1225.
88. Liu S.F., Newton R., Evans T.W., Barnes P.J. Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci. 90:1996;301-306.
89. Kapadia S., Lee J., Torre-Amione G., et al. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 96:1995;1042-1052.
90. Lowenstein C.J., Hill S.L., Lafond-Walker A., et al. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest. 97:1996;1837-1843.
91. Mikami S., Kawashima S., Kanazawa K., et al. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun. 220:1996;983-989.
92. Hiraoka Y., Kishimoto C., Takada H., et al. Nitric oxide and murine Coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide. J Am Coll Cardiol. 28:1996;1610-1615.
93. Ishiyama S., Hiroe M., Nishikawa T., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation. 95:1997;489-496.
94. Hirono S., Islam M.O., Nakazawa M., et al. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res. 80:1997;11-20.
95. Bachmaier K., Neu N., Pummerer C., et al. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation. 96:1997;585-591.
96. Drexler H., Kästner S., Strobel A., et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol. 32:1998;955-963.
97. Haywood G.A., Tsao P.S., von der Leyen H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
98. Habib F.M., Springall D.R., Daies G.J., et al. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
99. Vejlstrup N.G., Bouloumie A., Boesgaard S., et al. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol. 30:1998;1215-1223.
100. Stein B., Eschenhagen T., Rüdiger J., et al. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol. 32:1998;1179-1186.
101. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
102. Harding S.E., Davies C.H., Money-Kyrle A.M., Poole-Wilson P.A. An inhibitor of nitric oxide synthase does not increase contraction or β-adrenoceptor sensitivity of ventricular myocytes from failing human heart. Cardiovasc Res. 40:1998;523-529.
103. Heymes C, Vanderheyden M, Bronzwaer JGF, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 1999. In press.
104. Yang X., Chowdhury N., Cai B., et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 94:1994;714-721.
105. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673.
106. Cannon P.J., Yang X., Szabolcs M.J., et al. The role of inducible nitric oxide synthase in cardiac allograft rejection. Cardiovasc Res. 38:1998;6-15.
107. Worrall N.K., Chang K., Suau G.M., et al. Inhibition of inducible nitric oxide synthase prevents graft and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res. 78:1996;769-779.
108. Ziolo M.T., Dollinger S.J., Wahler G.M. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine. J Mol Cell Cardiol. 30:1998;1009-1017.
109. Lewis N.P., Tsao P.S., Rickenbacher P.R., et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 93:1996;720-729.
110. Russell M.E., Wallace A.F., Wyner L.R., Newell J.B., Karnovsky M.J. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 92:1995;457-464.
111. Koglin J., Glysing-Jensen T., Mudgett J.S., Russell M.E. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation. 97:1998;2059-2065.